Clinical trial

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

NCT00005615 · H. Lee Moffitt Cancer Center and Research Institute, Other · Completed

Key facts

NCT number NCT00005615
Title Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa
Official title The Florida Melanoma Trial: A Phase I/II Trial of Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa in the Treatment of Advanced Stage III Melanoma: Study Site & Coordinating Center
Lead sponsor H. Lee Moffitt Cancer Center and Research Institute, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Melanoma (Skin)
Intervention type Biological, Radiation
Interventions Interferon alfa, Radiation therapy
Enrollment 24
Start date Jul 1, 1997
Primary completion Dec 1, 2005
Completion Dec 1, 2005
First posted Apr 2, 2004
Last update posted Sep 25, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies